UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC  20549

Form 8-K


Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report: April 16, 2009


Cavit Sciences, Inc.
(Exact name of small business issuer as specified in its charter)

Commission File Number: 000-52263

           Florida           			            03-058693
  (State of incorporation)		                   (IRS Employer ID Number)

27 1st Avenue, Patterson, NJ. 07514
(Address of principal executive offices)

(973)-278-7327
(Issuer's telephone number)



Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:

[    ]	Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[    ]	Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
[    ]	Pre-commencement communications pursuant to Rule 14d-
2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[    ]	Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))




Item 4.01 - Changes in Registrants Certifying Accountant

Termination of Berkovits & Company

On April 13, 2009, the Board of Directors of Cavit Sciences, Inc. (a
Florida corporation) (Cavit or Company) has terminated its registered
independent certified public accounting firm, Berkovits & Company of
Ft. Lauderdale, Florida, effective immediately.

Berkovits & Company reported on the Companys financial statements
for the years ended December 31, 2007 and reviewed the Companys
financial statements for the quarter ended September 30, 2008.  For
these periods and up through April 13, 2009, there were no
disagreements with Berkovits & Company on any matter of accounting
principle or practices, financial statement disclosure or audit scope or
procedure, which disagreement(s), if not resolved to the satisfaction of
Berkovits & Company would have caused them to make reference
thereto in its report on the financial statements for such periods.
Further, there were no reportable events, as defined under Item
304(a)(1)(v) of Regulation S-K adopted by the SEC, during the years
ended December 31, 2007  and through April 13, 2009.

The report of Berkovits & Company on the financial statements of the
Company for the years ended December 31, 2007 did not contain any
adverse opinion or a disclaimer of opinion and were not qualified or
modified as to uncertainty, audit scope or accounting principles, except
for a going concern opinion expressing substantial doubt about the
ability of the Company to continue as a going concern.

The Company has provided Berkovits & Company with a copy of the
foregoing disclosure and requested that Berkovits & Company provide
the Company with a letter addressed to the U. S. Securities and
Exchange Commission stating whether it agrees with the statements
made by the Company in response to this item. A copy of such letter, is
filed as Exhibit 16.1 to this Current Report on Form 8-K.


Engagement of S. W. Hatfield, CPA

On April 13, 2009, subject to the completion of required professional
due diligence, the Companys Board of Directors announced that it
intends to engage S. W. Hatfield, CPA of Dallas, Texas (SWHCPA) as
the Companys new registered independent public accounting firm to
audit the Companys financial statements for the year ended
December 31, 2008.

The Company did not consult with SWHCPA at any time prior to April
13, 2009 including the Companys two most recent fiscal years ended
December 31, 2007, and the subsequent interim periods through the
date of this Report, with respect to the application of accounting
principles to a specified transaction, either completed or proposed, or
the type of audit opinion that might be rendered on the Companys
financial statements, or any other matters or reportable events set forth
in Item 304(a)(1)(v) of Regulation S-K.




SIGNATURES

In accordance with the requirements of the Securities Exchange Act of
1934, the registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

Cavit Sciences, Inc.

Dated: April 21, 2009                            /s/ Maggie Smyth
                                                                Maggie Smyth
                                                        Chief Executive Officer


Exhibit 16.1

Berkovits, Lago & Company, LLP
Certified Public Accountants and Consultants

April 21, 2009


Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561


Dear Sirs/Madams:

This letter will confirm that we reviewed Item 4.01 of
Cavit Sciences, Inc. Form 8-K dated April 21, 2009,
captioned Changes in the Registrants Certifying
Accountant and that we agree with such statements made
therein as they relate to Berkovits & Company, LLP.

We hereby consent to the filing of this letter as an exhibit
to the foregoing report on Form 8-K.

Yours truly,

/s/ Berkovits & Company, LLP
Fort Lauderdale, Florida
3
[{"type": "8-K", "sequence": "1", "filename": "k8401.txt", "secsgml_size_bytes": 5084}]
{"company-data": {"conformed-name": "Cavit Sciences, Inc.", "cik": "0001368502", "assigned-sic": "2834", "irs-number": "030586935", "state-of-incorporation": "FL", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-52263", "film-number": "09763042"}, "business-address": {"street1": "27 1ST AVE", "city": "PATERSON", "state": "NJ", "zip": "07514", "phone": "973-278-7327"}, "mail-address": {"street1": "P.O. BOX 222", "city": "OAK GROVE", "state": "MO", "zip": "64075"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC  20549

Form 8-K

Current Report
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report: April 16, 2009

Cavit Sciences, Inc.
(Exact name of small business issuer as specified in its charter)

Commission File Number: 000-52263

           Florida           			            03-058693
  (State of incorporation)		                   (IRS Employer ID Number)

27 1st Avenue, Patterson, NJ. 07514
(Address of principal executive offices)

(973)-278-7327
(Issuer's telephone number)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:

[    ]	Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[    ]	Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
[    ]	Pre-commencement communications pursuant to Rule 14d-
2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[    ]	Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))

Item 4.01 - Changes in Registrants Certifying Accountant

Termination of Berkovits & Company

On April 13, 2009, the Board of Directors of Cavit Sciences, Inc. (a
Florida corporation) (Cavit or Company) has terminated its registered
independent certified public accounting firm, Berkovits & Company of
Ft. Lauderdale, Florida, effective immediately.

Berkovits & Company reported on the Companys financial statements
for the years ended December 31, 2007 and reviewed the Companys
financial statements for the quarter ended September 30, 2008.  For
these periods and up through April 13, 2009, there were no
disagreements with Berkovits & Company on any matter of accounting
principle or practices, financial statement disclosure or audit scope or
procedure, which disagreement(s), if not resolved to the satisfaction of
Berkovits & Company would have caused them to make reference
thereto in its report on the financial statements for such periods.
Further, there were no reportable events, as defined under Item
304(a)(1)(v) of Regulation S-K adopted by the SEC, during the years
ended December 31, 2007  and through April 13, 2009.

The report of Berkovits & Company on the financial statements of the
Company for the years ended December 31, 2007 did not contain any
adverse opinion or a disclaimer of opinion and were not qualified or
modified as to uncertainty, audit scope or accounting principles, except
for a going concern opinion expressing substantial doubt about the
ability of the Company to continue as a going concern.

The Company has provided Berkovits & Company with a copy of the
foregoing disclosure and requested that Berkovits & Company provide
the Company with a letter addressed to the U. S. Securities and
Exchange Commission stating whether it agrees with the statements
made by the Company in response to this item. A copy of such letter, is
filed as Exhibit 16.1 to this Current Report on Form 8-K.

Engagement of S. W. Hatfield, CPA

On April 13, 2009, subject to the completion of required professional
due diligence, the Companys Board of Directors announced that it
intends to engage S. W. Hatfield, CPA of Dallas, Texas (SWHCPA) as
the Companys new registered independent public accounting firm to
audit the Companys financial statements for the year ended
December 31, 2008.

The Company did not consult with SWHCPA at any time prior to April
13, 2009 including the Companys two most recent fiscal years ended
December 31, 2007, and the subsequent interim periods through the
date of this Report, with respect to the application of accounting
principles to a specified transaction, either completed or proposed, or
the type of audit opinion that might be rendered on the Companys
financial statements, or any other matters or reportable events set forth
in Item 304(a)(1)(v) of Regulation S-K.

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of
1934, the registrant caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

Cavit Sciences, Inc.

Dated: April 21, 2009                            /s/ Maggie Smyth
                                                                Maggie Smyth
                                                        Chief Executive Officer

Exhibit 16.1

Berkovits, Lago & Company, LLP
Certified Public Accountants and Consultants

April 21, 2009

Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549-7561

Dear Sirs/Madams:

This letter will confirm that we reviewed Item 4.01 of
Cavit Sciences, Inc. Form 8-K dated April 21, 2009,
captioned Changes in the Registrants Certifying
Accountant and that we agree with such statements made
therein as they relate to Berkovits & Company, LLP.

We hereby consent to the filing of this letter as an exhibit
to the foregoing report on Form 8-K.

Yours truly,

/s/ Berkovits & Company, LLP
Fort Lauderdale, Florida
3